Pharmacokinetic Study Of Progesterone Capsules In Post Menopausal Females Of India Under Fasting Condition

Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/2105

Full metadata record

DC Field	Value	Language
dc.contributor.author	Panchal, Shital, J	-
dc.contributor.author	Patel, Jagruti, A	-
dc.date.accessioned	2011-04-27T11:30:19Z	-
dc.date.available	2011-04-27T11:30:19Z	-
dc.date.issued	2009	-
dc.identifier.uri	http://hdl.handle.net/123456789/2105	-
dc.description	Pharmacologyonline 3 , 2009, Page No. 1037-1046	en
dc.description.abstract	The study was conducted to assess the pharmacokinetics of micronized progesterone administered in the capsule form. Ten post-menopausal females of India, with a mean age of 51.50 years, volunteered to participate in the study. The pharmacokinetics of 200 mg of progesterone evaluated by validated Liquid Chromatography Mass Sepectroscopy-Mass spectroscopy (LCMS-MS) method. After the initial administration of 200 mg, a mean serum Cmax of 3.59±0.66 was reached at a tmax of 3.50±0.59. The terminal half-life (t1/2) was 7.09±2.52. Micronized progesterone given as a capsule is well tolerated, safe and an easily administered. Key Words: Pharmacokinetic, Progesterone, Post menopausal, females of India, LCMS-MS	en
dc.language.iso	en_US	en
dc.publisher	University of Salerno	en
dc.subject	Pharmacokinetic	en
dc.subject	Progesterone	en
dc.subject	Post menopausal females of India	en
dc.subject	LCMS-MS	en
dc.title	Pharmacokinetic Study Of Progesterone Capsules In Post Menopausal Females Of India Under Fasting Condition	en
dc.type	Faculty Paper	en
Appears in Collections:	Faculty Papers

Files in This Item:

File	Description	Size	Format
IPFP0008.pdf	IPFP0008	1.03 MB	Adobe PDF	View/Open

IR @ Nirma University